Sign up for our Weekly Checkup Newsletter
Back to News
Insights · News

OneOncology's Los Angeles practice adds an Orange County oncologist, California filing shows

The Los Angeles Cancer Network, the OneOncology partner practice now operating as Oncura Health, has agreed to absorb the Center for Cancer and Blood Disorders, a single-oncologist practice in Orange, California, according to a California Office of Health Care Affordability filing. No price was disclosed.

6 min read

The Los Angeles Cancer Network, the OneOncology partner practice that now operates as Oncura Health, has agreed to absorb the Center for Cancer and Blood Disorders, a single-oncologist practice in Orange, California, according to a material change notice posted by the state's Office of Health Care Affordability. The notice, which OHCA deemed complete on September 21, 2026, is the first OneOncology transaction to appear on the office's public list, and it arrives in the first year that California's expanded notice rules reach management services organizations and their investors.

What the filing says

The submitter is Los Angeles Hematology/Oncology Medical Group, the physician partnership that does business as the Los Angeles Cancer Network (LACN). Under the agreement described in the notice, OneOncology's West Coast services affiliate, OneOncology West, LLC, will buy the practice's non-clinical assets and LACN will buy the clinical assets, on a cash-free, debt-free basis, with consideration paid in cash at closing and in deferred cash. No figures are given. Stavroula A. Otis, M.D., who operates the Center for Cancer and Blood Disorders (CBCS), becomes a full-time physician partner in LACN's CCCMG Division. The anticipated closing date is November 1, 2026.

CBCS will remain in existence after closing only to collect its receivables and is then expected to wind down. LACN will hire its clinical staff and OneOncology West its non-clinical staff; the parties say no positions will be eliminated. Dr. Otis will continue to see patients from the same office. The notice also says the transaction preserves care for the patient panel of a departing CBCS physician, identified only as Dr. Spector, whose patients will be served by LACN physicians.

The filing is unusually specific about the target's size. CBCS reported revenue of $18.3 million in fiscal 2023, $21.7 million in fiscal 2024 and $24.4 million in fiscal 2025, a 33 percent increase over two years for what the parties describe as a sole-physician operation. Those figures tripped OHCA's filing test: the notice states the transaction is more likely than not to add at least $10 million, or 20 percent, to a party's California revenue.

LACN itself is described as a general partnership of California-licensed physicians organized into divisions, with 27 clinics across Los Angeles, Orange, Riverside and San Bernardino counties, 38 medical oncologists, seven gynecologic oncologists, one gastroenterologist and 47 advanced practice providers, and 121 non-clinical staff. It counted roughly 54,600 unique patients across the four counties in 2025, including 14,873 in Orange County. Services include medical and gynecologic oncology, infusion, in-office oral oncolytic dispensing and Phase 1 through 3 clinical trials; it accepts Medi-Cal and Medicare.

The practice being acquired

Dr. Otis trained at the Keck School of Medicine at USC, completed internal medicine at Baylor College of Medicine and a hematology-oncology fellowship at Stanford in 2011, and is board certified in hematology. Her corporation, the Center for Cancer and Blood Disorders, was formed in 2017 and practices from 363 South Main Street in Orange, across the street from Providence St. Joseph Hospital, where she chairs the weekly breast cancer conference and has served as principal investigator on Phase 3 breast cancer trials. Hospital affiliations listed for the group include St. Joseph, Providence Mission Hospital and Hoag.

The practice is unrelated to the Fort Worth, Texas group of the same name that joined OneOncology in 2020; the California entity is a separate corporation with its own tax identification, and the notice treats it as a stand-alone medical practice rather than a OneOncology affiliate.

LACN's build-out under OneOncology

LACN was OneOncology's first California partner. When it joined the platform in August 2020 it had 18 providers at nine Los Angeles sites and treated about 2,500 patients a year. Scope Research's database records the steps since: Dr. Shahrooz Eshaghian's Compassionate Oncology Medical Group in Century City joined in November 2022; Pacific Cancer Medical Center in Anaheim, with five oncologists, brought the practice into Orange County in January 2024; Compassionate Cancer Care Medical Group, a 14-physician group with five clinics in Orange and Riverside counties led by Dr. Haresh Jhangiani, joined in March 2024 and became the CCCMG Division that Dr. Otis will enter; and New Hope Cancer Institute in Pomona followed in November 2024. The practice rebranded as Oncura Health in early 2026 and opened a new Anaheim clinic in May. OneOncology's own reporting said LACN added 25 physicians in 2024 alone.

The Otis practice is the first Orange County addition since that rebrand, and it extends the CCCMG Division's footprint from Fountain Valley, Laguna Hills, Los Alamitos and Anaheim into the city of Orange, which sits in the orbit of Providence St. Joseph and City of Hope's new Irvine campus.

OneOncology after the Cencora buyout

The platform behind LACN changed hands this year. Cencora, which took a 35 percent stake in OneOncology alongside TPG in 2023, agreed in December 2025 to buy the equity it did not own and completed the purchase on February 2, 2026; physicians and management kept an 8 percent interest, and OneOncology now sits inside Cencora's U.S. Healthcare Solutions segment. At the time of the December agreement OneOncology described itself as a network of 36 partner practices with about 2,300 providers, roughly 1.5 million patients and more than 645 sites of care. Its California partners, besides LACN, are Medical Oncology Associates of San Diego (2022), Pacific Cancer Care in Monterey (2023, which added a Los Gatos radiation center in 2025) and Ventura County Hematology Oncology Specialists (December 2025). Scope's database holds more than 40 OneOncology and partner-practice acquisitions since 2019.

Cencora's appetite for community oncology did not stop there: on October 20, 2026 it agreed to acquire American Oncology Network, a physician network of more than 350 providers in 21 states, which would give the distributor two of the largest independent oncology platforms in the country.

Why the filing matters

The notice is notable less for its size than for who filed it and how. OneOncology and OneOncology West tell OHCA they are not "health care entities" or noticing entities under the office's rules; the obligation falls on LACN as the physician group. Assembly Bill 1415, in force since January 1, 2026, extended OHCA notice requirements to private equity groups, hedge funds and management services organizations, and OHCA finalized its implementing regulations in September 2026. Whether an MSO-affiliated practice acquisition is noticed by the practice, the MSO or both is exactly the kind of question the new rules were written to settle, and this filing shows one platform's answer.

OHCA has waived cost and market impact review on 50 of the 53 notices it has listed since the program began, including every oncology, laboratory and physician-platform transaction to date; its only full review was Res-Care's sale to Sevita, and one skilled nursing transaction is pending. The LACN notice lists November 5, 2026 as the date by which OHCA could waive review and November 20 as the date by which it could order one. As of October 30 the CMIR column on OHCA's table is blank. The parties' anticipated November 1 closing falls before either date.

What to watch

OHCA's waiver or review decision in early November; whether Oncura adds an Orange clinic to its locations page; and whether the next OneOncology practice additions in California, after the Ventura County and Los Gatos deals that were not noticed, now routinely appear on the OHCA list under the AB 1415 rules.

Sources: Material Change Notice 2026-07-30-1533, Los Angeles Hematology/Oncology Medical Group, with transaction description, California Office of Health Care Affordability, review start September 21, 2026 (https://hcai.ca.gov/wp-content/uploads/2026/09/LACN-MCN-Notice-with-Attachments.pdf); OHCA material change notice list (https://hcai.ca.gov/material-change-transaction-notices-mcn-and-cost-and-market-impact-review-cmir); OneOncology release on LACN joining the platform, August 2020 (https://www.oneoncology.com/blog/oneoncology-expands-to-southern-california-with-the-los-angeles-cancer-network-joining-the-platform); LACN releases on Pacific Cancer Medical Center (https://prnewswire.com/news-releases/los-angeles-cancer-network-expands-into-orange-county-302025437.html) and Compassionate Cancer Care Medical Group (https://prnewswire.com/news-releases/los-angeles-cancer-network-expands-reach-into-third-county-by-joining-forces-with-compassionate-cancer-care-medical-group-302105176.html); Oncura Health (https://www.oncurahealth.com/); Cencora 8-K exhibit, December 15, 2025 (https://www.sec.gov/Archives/edgar/data/1140859/000110465925120852/tm2533461d1_ex99-1.htm) and Form 10-Q for the quarter ended March 31, 2026 (https://www.sec.gov/Archives/edgar/data/0001140859/000114085926000020/cor-20260331.htm); Providence provider profile for Dr. Otis (https://www.providence.org/providers/profile/1477677557). Acquisition history from the Scope Research healthcare M&A database.